<DOC>
	<DOC>NCT00930722</DOC>
	<brief_summary>This is a prospective, non-interventional, non comparative drug study. The efficacy of Quinapril in Asian population has been evaluated, but specifically in Indian patients the data is sparse. Data in a real world setting in a large population of Indian patients would shed more light on the safety, tolerability and effectiveness of Quinapril in the Indian population.</brief_summary>
	<brief_title>A Non Interventional Study To Asses The Safety, Effectiveness And Tolerability Of Quinapril (Acupil速) In An Indian Population</brief_title>
	<detailed_description />
	<mesh_term>Quinapril</mesh_term>
	<criteria>Patients already on therapy with Acupil速 for a minimum period of 4 weeks, Evidence of a personally signed and dated informed consent document Patients having a Week 0 visit blood pressure reading of more than 180/110 mm of Hg will not be eligible to participate in the study. Women of child bearing age, not willing to use contraceptives, will not be eligible for the study Women using oral contraceptives will also not be included in the study Patients who have received any drug other than Acupil速 as the first prescribed antihypertensive would not be eligible for enrollment into the trial Patients having any complication at Week 0 visit which would require more thorough investigations or who required more than one antihypertensive drug at the time of initiation of their therapy will not be included in the study Patients having any contraindications as per the LPD of Acupil速</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Quinapril non-interventional/observational study safety</keyword>
</DOC>